Alzheimer’s disease

Halting the disease progression would lead to great benefits to patients, families and caregivers.

Read more

Parkinson’s disease

The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.

Read more

Complete Spinal Cord Injury

We are developing an innovative treatment that aims to improve the patients’ quality of life.

Read more

Press releases

• July 18, 2019 - Other press releaseBioArctic and Eisai present new data regarding BAN2401 at the Alzheimer’s Association International Conference 2019
• July 15, 2019 - Other press releaseBioArctic’s co-founder received AAIC Lifetime Achievement Award
• July 11, 2019 - Regulatory press releaseInterim Report January – June 2019

Archive

Interim Report Q2 2019

BioArctic AB published the company’s Interim Report for the period January – June 2019 on Thursday, July 11, 2019.

• Report
• Presentation
• Press release
• Webcast

Read the report

Calendar

• October 24, 2019Interim Report January – September 2019
• December 4, 2019 - December 7, 2019International Conference on Clinical Trials for Alzheimer’s Disease (CTAD)
• February 6, 2020Full Year Report 2019

All events